Site Map : Directions : Case Results

111 John Street, 14th Floor
New York, New York 10038
P: (212) 566-7500 | F: (212) 566-7501

Fighting For You

A National Law Firm

The law firm of Douglas & London, P.C., is one that provides legal services to victims and their families injured by acts of negligence and medical malpractice. Our firm focuses on product liability actions, including defective products, defective drugs and medical devices, as well medical malpractice, general negligence actions, toxic torts and consumer fraud cases.

With many years of combined litigation experience and over $875 million dollars in verdicts and settlements for the injured across the country, Douglas & London fights for your rights.

At Douglas & London, no case is too difficult and no defendant too big.

Call now to speak to our knowledgeable staff and receive a free full case evaluation or submit an online free and instant case evaluation form.

*Prior results do not guarantee a similar outcome.

News & Events

Breaking News
URGENT MESSAGE FOR PRADAXA USERS!!!This is an important medical alert from Douglas & London, P.C. for people who have taken the prescription drug PRADAXA.  Pradaxa (dabigatran) is a drug often prescribed to prevent strokes and assist in reducing the risk of blood clots frequently assoc...
Read More posted by: on: Apr 10, 2012 @ 11:06
Breaking News
Douglas & London, P.C., is representing individuals diagnosed with bladder cancer after taking Actos. You may be entitled to compensation from the manufacturer for your injuries. For your free legal consultation fill out our online Contact Form. The United States Food and Drug Administratio...
Read More posted by: on: Sep 23, 2011 @ 10:24
Breaking News
Tell Albany "NO". There will be a bill voted on in Albany on 4/1/11 which seeks to "cap" damages in medical malpractice suits. This would have devastating consequences for medical malpractice victims and possibly all innocent New Yorkers who may be harmed by someone else's negligence. Plea...
Read More posted by: on: Mar 21, 2011 @ 01:38
News Archives